Update from ASH 2018 #2
Update from ASH 2018 #2
LYMPHOMA CONNECT has summarised the highlights from ASH 2018 for you. An Update on Prognostic Factors in Indolent Lymphomas by Prof. Stefano Luminari, University of Modena and Reggio Emilia, Italy. Abstract 393 – Luminari et al LYMPHOMA CONNECT has summarised the highlights from ASH 2018 for you. An Update on Prognostic Factors in Indolent Lymphomas by Prof. Stefano Luminari, University of Modena and Reggio Emilia, Italy. Abstract 393 – Luminari et alProf. Stefano Luminari
Watch the video and download the slidesProf. Stefano Luminari
Haematologist
University of Modena and Reggio Emilia
Italy
Prof Stefano Luminari is Hematologist, Associate professor of Medical Oncology at the University of Modena and Reggio Emilia, in Italy. He is head of the clinical research program for oncohematologic disorders at the Reggio Emilia research Hospital. His activity has been mainly focused on several aspects of clinical research in malignant lymphomas. In particular he is an expert in biomarkers and prognostic studies, in phase II and III clinical trials, and in population based studies. He is an active member of the Fondazione Italiana Linfomi with a leading role in the Indolent lymphoma committee and with a role as PI or co-investigator in several clinical trials mainly focused on follicular lymphomas, Hodgkin lymphomas, aggressive lymphomas (mainly elderly patients) and in the use of PET in lymphomas. He has authored more than 130 peer reviewed manuscripts. Of note, his contribution in the study of FDG-PET in Follicular Lymphoma in the staging (Luminari et al Ann Oncol 2013) and restaging assessment after induction therapy (Luminari et al. Ann Oncol 2014, Trotman J et al. Lancet Hematol 2014) and in the integration of PET with minimal residual disease in the phase of response assessment (Luminari Haematologia 2015). He is active in communicating research data and opinions through social networks (twitter account @stefanoluminari)
Prof. Stefano Luminari has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
| 5 min | 2018
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
To hear Prof. Stefano Luminari summarising additional abstracts, please visit the links below:
Abstract 2873 – Freeman et al
Abstract 4095 – Silva et al
Abstract 396 – Pott et al
LYMPHOMA & MYELOMA CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer and from Karyopharm Therapeutics.
Other programmes of interest
Other programmes developed by Prof. Stefano Luminari
Prof. Stefano Luminari
Haematologist
University of Modena and Reggio Emilia
Italy